Inventor · Nanjing, CN

Fei Liu

27Patents
1h-index
110Co-inventors
56Inventor score

Filing activity: Dec 23, 2010 → Apr 27, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US10376512B1 Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereof Human Necessities 2 Active
US10913721B2 Crystalline form of aripiprazole Chemistry; Metallurgy 1 Active
US10080746B2 Donepezil derivative and use thereof Human Necessities 1 Active
US10231973B2 Salts of quinazoline derivative and method for preparing the same Human Necessities 1 Active
US10858340B2 Crystal of salt of quinazoline derivative Chemistry; Metallurgy 0 Active
US12319689B2 Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor Human Necessities 0 Active
US11786522B2 Aripiprazole injectable suspension formulation having prolonged shelf life Human Necessities 0 Active
US11279676B2 Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof Chemistry; Metallurgy 0 Active
US10023582B2 6-aryl amino pyridone formamide compound crystal and preparation method therefor Chemistry; Metallurgy 0 Active
US10632111B2 Donepezil derivative and use thereof Human Necessities 0 Active
US10961203B2 Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Chemistry; Metallurgy 0 Active
US10745363B2 Crystal forms of valsartan disodium salt Chemistry; Metallurgy 0 Active
US10732109B2 Core-shell type nanosilica fluorescent probe and synthesis method and use thereof Physics 0 Active
US10450328B2 Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US12358913B2 Crystal of diarylthiohydantoin compound Chemistry; Metallurgy 0 Active
US8569322B2 Lamivudine oxalate and preparation method thereof Human Necessities 0 Active
US12187710B2 Salt of Syk inhibitor and crystalline form thereof Chemistry; Metallurgy 0 Active
US11021464B2 Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt Chemistry; Metallurgy 0 Active
US10683260B2 Crystalline form of sacubitril sodium salt Chemistry; Metallurgy 0 Active
US12371431B2 Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor Human Necessities 0 Active
US10501468B2 Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as MEK inhibitor Chemistry; Metallurgy 0 Active
US11773079B2 Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine Chemistry; Metallurgy 0 Active
US11376274B2 Joint cavity injection preparation and use thereof Human Necessities 0 Active
US10351825B2 Mesenchymal stem cells derived from induced pluripotent stem cells Chemistry; Metallurgy 0 Active
US12358891B2 Crystals of quinolone derivatives Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.